Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks. Unlock full list
Close

Tilray Inc (0Z6Y)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
Tilray historical data, for real-time data please try another search
2.65 -15.46    -85.37%
05/05 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United Kingdom
ISIN:  US88688T1007 
SEDOL:  BGV70Z6
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 2.65 - 2.65
Tilray 2.65 -15.46 -85.37%

Tilray Inc Class 2 Company Profile

 
Get an in-depth profile of Tilray Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

1600

Equity Type

DRC

Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. In addition, the company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.

Contact Information

Address 265 Talbot Street West
Leamington, N8H 5L4
Canada
Phone 844-845-7291
Fax -
Web www.tilray.com

Top Executives

Name Age Since Title
Jodi Lynn Heimpel Butts 50 2019 Independent Director
Thomas P. Looney 59 2018 Independent Director
John M. Herhalt 65 2018 Independent Director
Irwin David Simon 65 2018 President, CEO & Chairman
Joschka Fischer 75 2021 Member of International Advisory Board
Jaime Gama - 2021 Member of International Advisory Board
David G. Hopkinson 51 2019 Independent Director
Gerard Araud 68 2021 Member of International Advisory Board
Alexander John Gosse Downer 71 2021 Member of International Advisory Board
Michael S. Steele 65 2021 Member of International Advisory Board
Lorna R. Marsden 81 2021 Member of International Advisory Board
David F. Clanachan 61 2021 Independent Director
Donald McKinnon - 2021 Member of International Advisory Board
James C. O'Brien - 2021 Member of International Advisory Board
Renah A. Persofsky 65 2017 Independent Vice Chairman & Lead Director
Lloyd Axworthy 83 2021 Member of International Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

TLRY Comments

Write your thoughts about Tilray Inc Class 2
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
GAS BULL
GAS BULL 1 hour ago
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
this junk isnt moving up on any news
Reply
2 0
Report
Joe Cool
Joe Cool 2 hours ago
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
move the needle ''' let's go a hole bears cover and move on
Reply
1 0
Report
Joe Cool
Joe Cool 3 hours ago
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
stop the naked shorts turn off this pos algorithm
Reply
2 0
Report
Tropical Breeze
Tropical_Breeze 6 hours ago
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I am taking upwards of 30 day break here. Got a friend who does really well in crypto. Convincing me to buy Avalanche. Says high probability it will be over $100 by mid June. I will take that chance and it's a nice break. Bought $40.67. GL all
Reply
3 0
Report
Tropical Breeze
Tropical_Breeze 15 hours ago
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Truth Social (aka Trump Media & Technology Group Corp) lost $328 million in the first quarter of 2024 Total revenue was $770,500 THIS COMPANY HAS A MARKET CAP OF $6 BILLION
Reply
2 0
Report
Tropical Breeze
Tropical_Breeze 15 hours ago
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
You can't tell me foreign and domestic entries aren't pumping money in to get favors
Reply
2 0
Report
GAS BULL
GAS BULL 16 hours ago
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Reuters reported in recent weeks that prosecutors and other regulators are looking at short-selling activity in bank shares, which have whipsawed following three bank failures since March. Since at least 2021, the Justice Department and the U.S. Securities and Exchange Commission have been investigating potential manipulation by short sellers and hedge funds around the publication of negative research reports. The broad probe is an example of the agency’s efforts to use data to root out potential misconduct by traders and to dig more deeply into securities markets. Perry also said that cases against executives who misuse corporate trading plans and spoofing - a type of futures market manipulation technique - remain priority areas.
Reply
2 1
Report
Joe Cool
Joe Cool 14 hours ago
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
naked shorts
Reply
0 0
Report
Joe Cool
Joe Cool 23 hours ago
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
cmo 2.50 gap close squeeze party
Reply
1 0
Report
Joe Cool
Joe Cool May 20, 2024 1:03PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
push it to limit tony Montana
Reply
1 0
Report
Douglas Heffron
Douglas Heffron May 20, 2024 12:41PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
the best way to combat share dilution is increasing revenue. let's hope there is another acquisition in the works. Not sure the nu.ber of stores Medmen still has but that would be one possible buyout, another could be curaleaf. Only way to break the backs of the whales in a speculative market is to show real revenue growth, at which time the whales will gladly flip sides and springs hot this an other pot stocks forward.
Reply
1 2
Report
Ajay Bhandari
Ajay Bhandari May 20, 2024 12:35PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
How many of us approve this dilution. I disapprove this nonsense. No more dilution, stand up on your own leg or just die on your own. First show that you can make money. Stop wasting shareholders money. Tilray is committing sin to existing shareholders.
Reply
4 1
Report
Idan Molcho
Idan Molcho May 20, 2024 12:35PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
tilrays mgmt are one of the biggest thives on wallstreet. since always. fat salaries, slim results
Reply
3 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email